Image credit: Jasleen Kaur

White House Request for Comments on Equity and Drug Policy Spurs Slew of Cannabis Responses

In response to an Office of National Drug Control Policy request for information on the “application of equity in U.S. national drug control policy,” there was a significant focus on cannabis.

United States
Regulation

House Lawmakers Push Top FDA Official on Hemp Products and Cannabis Rescheduling 

The conversation covered the proliferation of intoxicating hemp products, as well as the timeline for the federal review of whether to move cannabis from Schedule I to III.

New York

New York Cannabis Regulators Celebrate 100-Store Milestone, Forecast Market Changes Ahead

On Thursday, the state’s cannabis regulators talked about pitfalls to avoid as New York’s market matures.